DRAK2 抗体 (C-Term)
(3 references)Our Local Distributor
北京 101111
Quick Overview for DRAK2 抗体 (C-Term) (ABIN1882073)
抗原
See all DRAK2 (STK17B) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 342-371, C-Term
-
纯化方法
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
免疫原
- This DRAK2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 342-371 amino acids from the C-terminal region of human DRAK2.
-
亚型
- Ig Fraction
-
-
anti-serine/threonine Kinase 17b (STK17B) (AA 272-372) antibody
STK17B 适用: 人 ELISA, WB, IHC (p), IF 宿主: 小鼠 Monoclonal 2C3 unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 235-366) antibodySTK17B 适用: 人 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) antibodySTK17B 适用: 人 WB, FACS 宿主: 兔 Monoclonal 25GB1845 unconjugated Recombinant Antibody
anti-serine/threonine Kinase 17b (STK17B) antibodySTK17B 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodySTK17B 适用: 人, 小鼠, 大鼠 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Internal Region) antibodyVerified STK17B 适用: 人 ELISA, WB 宿主: 山羊 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B 适用: 人, 小鼠, 大鼠 ELISA, WB, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (AA 1-372) antibodySTK17B 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (Center) antibodySTK17B 适用: 人, 小鼠, 大鼠, Cow WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-serine/threonine Kinase 17b (STK17B) (C-Term) antibodySTK17B 适用: 人 WB, IF, EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- IF: 1:10~50. WB: 1:1000. IHC-P: 1:50~100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
-
: "Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 8, pp. 4762-70, (2009) (PubMed).
: "Transgenic drak2 overexpression in mice leads to increased T cell apoptosis and compromised memory T cell development." in: The Journal of biological chemistry, Vol. 281, Issue 18, pp. 12587-95, (2006) (PubMed).
: "DRAKs, novel serine/threonine kinases related to death-associated protein kinase that trigger apoptosis." in: The Journal of biological chemistry, Vol. 273, Issue 44, pp. 29066-71, (1998) (PubMed).
-
: "Drak2 is upstream of p70S6 kinase: its implication in cytokine-induced islet apoptosis, diabetes, and islet transplantation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 8, pp. 4762-70, (2009) (PubMed).
-
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
-
别名
- DRAK2
-
背景
- DRAK2 is a novel serine/threonine kinase that induces apoptosis via catalytic activity. DRAKs present high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases. DRAK2 is located in nucleus, and the messenger RNA is ubiquitously expressed in human tissues.
-
分子量
- 42344
-
NCBI登录号
- NP_004217
-
UniProt
- O94768
抗原
-
